CONSULTANTS COLLABORATIVE -- MATTHEW R. SIMMONS

Lobbying Income

$645K

Filings

Unique Clients

Active Period

2005–2010

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2010	$105,000	3	1
2009	$102,500	5	2
2008	$172,500	12	3
2007	$145,000	6	3
2006	$60,000	9	3
2005	$60,000	2	1

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
NATIONAL COALITION OF PHARMACEUTICAL DISTRIBUTORS	$510,000	15	2006–2010
BAJAGUA PROJECT	$75,000	9	2006–2008
PACIFIC EQUITY PARTNERS	$60,000	13	2005–2009

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	25
SENATE	24
Food & Drug Administration (FDA)	7
Small Business Administration (SBA)	5
Drug Enforcement Administration (DEA)	3
Federal Trade Commission (FTC)	1
Government Accountability Office (GAO)	1
Justice, Dept of (DOJ)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	16
Environment/Superfund	Environment/Superfund	8
Government Issues	Government Issues	3
Clean Air and Water (quality)	Clean Air and Water (quality)	3
Energy/Nuclear	Energy/Nuclear	1
Budget/Appropriations	Budget/Appropriations	1
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	1
Real Estate/Land Use/Conservation	Real Estate/Land Use/Conservation	1
Waste (hazardous/solid/interstate/nuclear)	Waste (hazardous/solid/interstate/nuclear)	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5839110th Congress

Safeguarding America's Pharmaceuticals Act of 2008

Cited source text and reported amounts

Support for H.R. 5839

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5839

CONSULTANTS COLLABORATIVE -- MATTHEW R. SIMMONS — Lobbying Disclosure | Poliscope